Publication | Closed Access

Decreased VLDL apoprotein CII/apoprotein CIII ratio may be seen in both normotriglyceridemic and hypertriglyceridemic patients on chronic hemodialysis treatment

Hypertriglyceridemic PatientsMetabolic SyndromeHemodialysisHypertensionCardiovascular DiseaseDiabetesChronic Kidney DiseaseHyperlipidemiaDialysis TherapyChronic Hemodialysis TreatmentCii/apoprotein Ciii RatioMedicineAtherosclerosisNephrologyDyslipidemia